Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior

Abroad (travel likely)Recruiting

Conditions

Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
Contact: Study coordinator (Clinical Trials Office - Lineberger Comprehensive Cancer Cente) · 877-668-0683

Study leads

Lisa A. Carey, MD
Principal Investigator
UNC Lineberger Comprehensive Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer

Anatomic Stage III Breast Cancer AJCC v8 · Anatomic Stage IV Breast Cancer AJCC v8 · Locally Advanced Unresectable Triple-Negative Breast Carcinoma

Abroad (travel likely)RecruitingPHASE2

Buffalo, United States

Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors

Female Breast Cancer · Prostate Cancer · Colorectal Carcinoma

Abroad (travel likely)Recruiting

Detroit, United States

A Prospective, Multicenter, Observational Cohort Study to Evaluate the Efficacy and Safety of a Novel Anti-tumor Drug as a Radiosensitizer in Patients With Advanced Breast Cancer Brain Metastasis.

Advanced Breast Cancer Brain Metastasis

Abroad (travel likely)Recruiting

Beijing, China

VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients

Breast Cancer

Abroad (travel likely)Recruiting

Chapel Hill, United States